Application Note: AAV manufacturing workflow
18 September 2023

In this application note, Cytiva provides information on the objectives, considerations, and strategies for each step of an adeno-associated virus (AAV) manufacturing workflow. AAV is a crucial tool in genetic research and gene therapy. It efficiently delivers genetic material into target cells, aiding in the study of gene function and offering potential treatments for genetic diseases. Its nonpathogenic nature and tissue-specific variants make it a promising candidate for advancing medical therapies and improving patient outcomes.